| DERL3 High (N=267) |
DERL3 Low (N=268) |
P-value | |
|---|---|---|---|
| sex | |||
| FEMALE | 89 (33.3%) | 97 (36.2%) | 0.546 |
| MALE | 178 (66.7%) | 171 (63.8%) | |
| age | |||
| older | 140 (52.4%) | 128 (47.8%) | 0.32 |
| younger | 127 (47.6%) | 140 (52.2%) | |
| stage | |||
| I/II | 138 (51.7%) | 191 (71.3%) | <0.001 |
| III/IV | 129 (48.3%) | 77 (28.7%) | |
| grade | |||
| G1 | 3 (1.1%) | 11 (4.1%) | <0.001 |
| G2 | 97 (36.3%) | 134 (50.0%) | |
| G3 | 112 (41.9%) | 97 (36.2%) | |
| G4 | 54 (20.2%) | 21 (7.8%) | |
| GX | 1 (0.4%) | 5 (1.9%) | |
| T | |||
| T1/2 | 149 (55.8%) | 196 (73.1%) | <0.001 |
| T3/4 | 118 (44.2%) | 72 (26.9%) | |
| N | |||
| N0 | 122 (45.7%) | 118 (44.0%) | 0.0284 |
| N1 | 13 (4.9%) | 3 (1.1%) | |
| NX | 132 (49.4%) | 147 (54.9%) | |
| M | |||
| M0 | 195 (73.0%) | 229 (85.4%) | 0.00115 |
| M1 | 53 (19.9%) | 25 (9.3%) | |
| MX | 19 (7.1%) | 14 (5.2%) | |
| pharmaceutical | |||
| NO | 218 (81.6%) | 242 (90.3%) | 0.00583 |
| YES | 49 (18.4%) | 26 (9.7%) | |
| smoking | |||
| less | 161 (60.3%) | 140 (52.2%) | 0.0731 |
| more | 106 (39.7%) | 128 (47.8%) | |
| Event | |||
| 0 | 158 (59.2%) | 204 (76.1%) | <0.001 |
| 1 | 109 (40.8%) | 64 (23.9%) |